• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA作为越南女性乳腺癌生物标志物的性能。

Performance of mRNA as a biomarker for breast cancer among Vietnamese women.

作者信息

Nguyen Hien Minh, Dao Minh Quang, La Huyen Thi

机构信息

Thanh Nhan Hospital, Hanoi, Viet Nam.

Institute of Biotechnology, Vietnam Academy of Science and Technology, Hanoi, Viet Nam.

出版信息

Heliyon. 2019 Mar 20;5(3):e01371. doi: 10.1016/j.heliyon.2019.e01371. eCollection 2019 Mar.

DOI:10.1016/j.heliyon.2019.e01371
PMID:30957048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6431741/
Abstract

OBJECTIVE

This study aimed to perform the reverse-transcription polymerase chain reaction (RT-PCR) to express the mRNA among patients with breast cancer in Vietnam and identify some potential associated clinical and pathological factors.

METHODS

Peripheral blood (PB) samples and tissues on 43 patients with breast cancer and 21 patients with fibroids were obtained. The Real-time RT-PCR and gene sequencing techniques were employed to detect survivin gene in breast cancer cell lines and cancer tissues.

RESULTS

mRNA transcription was detected in 32/43 (74,4%) of breast cancer tissues and 19/43 (44,2%) of PB samples of breast cancer patients, while it was detected in only 14,3 % fibrosis tissues and 0% in the blood of fibrosis patients. mRNA on the peripheral blood of breast cancer patients increased with tumor size, and stage of cancer (p < 0.05). In terms of breast cancer tissue, no difference was found in the rate of mRNA expression in according to age, distant metastasis, lymph node, stages of cancer, and histopathology (p > 0.05).

CONCLUSIONS

Results provide the initial evidence of the expression of survivin mRNA in breast cancer patients in Vietnam, suggesting the role of mRNA in breast cancer molecular pathology.

摘要

目的

本研究旨在通过逆转录聚合酶链反应(RT-PCR)检测越南乳腺癌患者的mRNA表达情况,并确定一些潜在的相关临床和病理因素。

方法

采集43例乳腺癌患者和21例纤维瘤患者的外周血(PB)样本及组织。采用实时RT-PCR和基因测序技术检测乳腺癌细胞系和癌组织中的生存素基因。

结果

在43例乳腺癌组织中的32例(74.4%)和乳腺癌患者PB样本中的19例(44.2%)检测到mRNA转录,而在纤维瘤组织中仅14.3%检测到,在纤维瘤患者血液中未检测到。乳腺癌患者外周血中的mRNA随肿瘤大小和癌症分期增加(p<0.05)。在乳腺癌组织方面,根据年龄、远处转移、淋巴结、癌症分期和组织病理学,mRNA表达率未发现差异(p>0.05)。

结论

结果为越南乳腺癌患者生存素mRNA表达提供了初步证据,提示mRNA在乳腺癌分子病理学中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d120/6431741/5fedacbb9d38/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d120/6431741/ec85d472f073/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d120/6431741/5fedacbb9d38/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d120/6431741/ec85d472f073/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d120/6431741/5fedacbb9d38/gr2.jpg

相似文献

1
Performance of mRNA as a biomarker for breast cancer among Vietnamese women.mRNA作为越南女性乳腺癌生物标志物的性能。
Heliyon. 2019 Mar 20;5(3):e01371. doi: 10.1016/j.heliyon.2019.e01371. eCollection 2019 Mar.
2
Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women.越南女性乳腺癌细胞中人乳腺珠蛋白mRNA的检测
Breast Cancer (Dove Med Press). 2019 Mar 18;11:143-150. doi: 10.2147/BCTT.S193777. eCollection 2019.
3
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.高生存素mRNA表达是乳腺癌预后不良的一个预测指标:一项mRNA和蛋白质水平的比较研究。
Breast Cancer. 2014 Jul;21(4):482-90. doi: 10.1007/s12282-012-0403-9. Epub 2012 Sep 12.
4
Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.Ⅰ期非小细胞肺癌患者区域淋巴结微转移的基因诊断:对分期和预后的影响。
Clin Transl Oncol. 2013 Nov;15(11):882-8. doi: 10.1007/s12094-013-1017-1. Epub 2013 Feb 12.
5
Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.应用逆转录聚合酶链反应酶联免疫吸附测定法检测乳腺癌患者外周血中表达生存素的循环癌细胞。
Clin Exp Metastasis. 2006;23(5-6):279-89. doi: 10.1007/s10585-006-9037-7. Epub 2006 Nov 3.
6
The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.采用多标志物(Survivin、hTERT和hMAM)定量实时PCR检测乳腺癌患者循环肿瘤细胞
Clin Biochem. 2009 Feb;42(3):194-200. doi: 10.1016/j.clinbiochem.2008.10.016. Epub 2008 Nov 6.
7
Clinical significance of survivin and vascular endothelial growth factor mRNA detection in the peripheral whole blood of breast cancer patients.乳腺癌患者外周血循环中 survivin 和血管内皮生长因子 mRNA 的检测及其临床意义。
Neoplasma. 2016;63(1):133-40. doi: 10.4149/neo_2016_016.
8
Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.胃癌中生存素mRNA表达与淋巴结转移的相关性
Gastric Cancer. 2003;6(4):217-24. doi: 10.1007/s10120-003-0255-2.
9
Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.结直肠癌患者外周血中生存素、细胞角蛋白20和癌胚抗原的定量实时逆转录聚合酶链反应检测
Jpn J Clin Oncol. 2008 Nov;38(11):770-6. doi: 10.1093/jjco/hyn105. Epub 2008 Oct 8.
10
Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer.Survivin 调控乳腺癌淋巴转移中 VEGF-C 的表达。
Diagn Pathol. 2012 May 18;7:52. doi: 10.1186/1746-1596-7-52.

引用本文的文献

1
Lovastatin Targets the USP14-Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal Degradation.洛伐他汀通过泛素介导的蛋白酶体降解作用靶向USP14-生存素轴以抑制三阴性乳腺癌。
Cells. 2025 May 31;14(11):816. doi: 10.3390/cells14110816.
2
Role of hypoxia-inducible factor-1α and survivin in breast cancer recurrence and prognosis.缺氧诱导因子-1α和生存素在乳腺癌复发及预后中的作用
Heliyon. 2023 Mar 1;9(3):e14132. doi: 10.1016/j.heliyon.2023.e14132. eCollection 2023 Mar.

本文引用的文献

1
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数,1990 年至 2015 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
2
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.高生存素mRNA表达是乳腺癌预后不良的一个预测指标:一项mRNA和蛋白质水平的比较研究。
Breast Cancer. 2014 Jul;21(4):482-90. doi: 10.1007/s12282-012-0403-9. Epub 2012 Sep 12.
3
Expression of survivin and VEGF-C in breast cancer tissue and its relation to lymphatic metastasis.survivin和VEGF-C在乳腺癌组织中的表达及其与淋巴转移的关系。
Eur J Gynaecol Oncol. 2012;33(2):178-82.
4
Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer.总 Survivin 和乙酰化 Survivin 与乳腺癌的不同分子亚型相关。
Hum Pathol. 2012 Jun;43(6):865-73. doi: 10.1016/j.humpath.2011.07.014. Epub 2011 Nov 4.
5
Survivin expression and targeting in breast cancer.Survivin 在乳腺癌中的表达和靶向治疗。
Surg Oncol. 2012 Jun;21(2):125-31. doi: 10.1016/j.suronc.2011.01.001. Epub 2011 Feb 19.
6
Innovative biomarker development for personalized medicine in breast cancer care.乳腺癌护理中用于个性化医疗的创新生物标志物开发。
Biomark Med. 2011 Feb;5(1):73-8. doi: 10.2217/bmm.10.116.
7
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?在小(<=1cm)浸润性乳腺癌中,通过激素受体(ER、PgR)和 HER-2 状态进行风险分层:哪些患者可能是辅助治疗的候选者?
Breast Cancer Res Treat. 2010 Feb;119(3):653-61. doi: 10.1007/s10549-009-0665-x.
8
Survivin as a global target of intrinsic tumor suppression networks.生存素作为肿瘤内在抑制网络的整体靶点。
Cell Cycle. 2009 Sep 1;8(17):2708-10. doi: 10.4161/cc.8.17.9457. Epub 2009 Sep 7.
9
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.HER-2受体与乳腺癌:十年靶向抗HER-2治疗及个性化医疗
Oncologist. 2009 Apr;14(4):320-68. doi: 10.1634/theoncologist.2008-0230. Epub 2009 Apr 3.
10
Advances in breast cancer: pathways to personalized medicine.乳腺癌的进展:个性化医疗之路
Clin Cancer Res. 2008 Dec 15;14(24):7988-99. doi: 10.1158/1078-0432.CCR-08-1211.